PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Pacific Biosciences Of California, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Pacific Biosciences Of California, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 178 %, a 0.45% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 178 -0.81 -0.45% Sep 30, 2024
Q2 2024 162 -28.7 -15.1% Jun 30, 2024
Q1 2024 160 -27.2 -14.5% Mar 31, 2024
Q4 2023 164 -20 -10.9% Dec 31, 2023
Q3 2023 178 +8.94 +5.27% Sep 30, 2023
Q2 2023 190 +32.8 +20.8% Jun 30, 2023
Q1 2023 187 +11.8 +6.75% Mar 31, 2023
Q4 2022 184 -17.4 -8.63% Dec 31, 2022
Q3 2022 170 -18.9 -10% Sep 30, 2022
Q2 2022 158 -62.4 -28.4% Jun 30, 2022
Q1 2022 175 -1.91 -1.08% Mar 31, 2022
Q4 2021 201 +96.2 +91.4% Dec 31, 2021
Q3 2021 188 -24.9 -11.7% Sep 30, 2021
Q2 2021 220 -37.4 -14.5% Jun 30, 2021
Q1 2021 177 -11.8 -6.24% Mar 31, 2021
Q4 2020 105 -30 -22.2% Dec 31, 2020
Q3 2020 213 +113 +113% Sep 30, 2020
Q2 2020 257 +187 +266% Jun 30, 2020
Q1 2020 189 +130 +223% Mar 31, 2020
Q4 2019 135 +86.1 +175% Dec 31, 2019
Q3 2019 100 +47.5 +89.8% Sep 30, 2019
Q2 2019 70.3 +11.7 +19.9% Jun 30, 2019
Q1 2019 58.5 +1.73 +3.05% Mar 31, 2019
Q4 2018 49.1 -16.1 -24.7% Dec 31, 2018
Q3 2018 52.9 -11.3 -17.6% Sep 30, 2018
Q2 2018 58.6 -4.77 -7.52% Jun 30, 2018
Q1 2018 56.8 -5.52 -8.86% Mar 31, 2018
Q4 2017 65.2 +9.98 +18.1% Dec 31, 2017
Q3 2017 64.2 +6.11 +10.5% Sep 30, 2017
Q2 2017 63.4 -7.39 -10.4% Jun 30, 2017
Q1 2017 62.3 -34.6 -35.7% Mar 31, 2017
Q4 2016 55.2 -74.2 -57.3% Dec 31, 2016
Q3 2016 58 -92.4 -61.4% Sep 30, 2016
Q2 2016 70.8 -75.7 -51.7% Jun 30, 2016
Q1 2016 97 -34.7 -26.4% Mar 31, 2016
Q4 2015 129 +16.9 +15.1% Dec 31, 2015
Q3 2015 150 +45.2 +42.9% Sep 30, 2015
Q2 2015 146 +52.1 +55.2% Jun 30, 2015
Q1 2015 132 +60 +83.7% Mar 31, 2015
Q4 2014 112 +56.2 +99.8% Dec 31, 2014
Q3 2014 105 +66.3 +170% Sep 30, 2014
Q2 2014 94.3 +70.4 +294% Jun 30, 2014
Q1 2014 71.7 +52.6 +275% Mar 31, 2014
Q4 2013 56.3 +40.3 +252% Dec 31, 2013
Q3 2013 39 +24 +161% Sep 30, 2013
Q2 2013 23.9 +9.62 +67.3% Jun 30, 2013
Q1 2013 19.1 +5.59 +41.3% Mar 31, 2013
Q4 2012 16 Dec 31, 2012
Q3 2012 15 Sep 30, 2012
Q2 2012 14.3 Jun 30, 2012
Q1 2012 13.6 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.